EMT and tumor metastasis

[1]  N. Wong,et al.  Transforming growth factor‐β–induced long noncoding RNA promotes liver cancer metastasis via RNA–RNA crosstalk , 2015, Hepatology.

[2]  R. Dummer,et al.  PI3K signalling is required for a TGFβ‐induced epithelial–mesenchymal‐like transition (EMT‐like) in human melanoma cells , 2015, Experimental dermatology.

[3]  S. Sarkar,et al.  Methylation by DNMT1 is more Efficient in Chronic LymphocyticLymphoma Cells than in Normal Cells , 2014 .

[4]  J. Cebon,et al.  Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells , 2014, Front. Oncol..

[5]  Jill M Dowen,et al.  Control of Cell Identity Genes Occurs in Insulated Neighborhoods in Mammalian Chromosomes , 2014, Cell.

[6]  D. Ma,et al.  Twist2, the key Twist isoform related to prognosis, promotes invasion of cervical cancer by inducing epithelial-mesenchymal transition and blocking senescence. , 2014, Human pathology.

[7]  Sarah A Heerboth,et al.  Drug Resistance in Cancer: An Overview , 2014, Cancers.

[8]  W. Park,et al.  EGF-induced expression of Fused Toes Homolog (FTS) facilitates epithelial-mesenchymal transition and promotes cell migration in ME180 cervical cancer cells. , 2014, Cancer letters.

[9]  L. Wang,et al.  The DNA methylation-regulated miR-193a-3p dictates the multi-chemoresistance of bladder cancer via repression of SRSF2/PLAU/HIC2 expression , 2014, Cell Death and Disease.

[10]  Xiangshan Yang,et al.  The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas , 2014, Tumor Biology.

[11]  Xia Han,et al.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives , 2014, Tumor Biology.

[12]  G. Mills,et al.  hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness , 2014, Oncogene.

[13]  A. Schrader,et al.  Clinical significance of epithelial-mesenchymal transition , 2014, Clinical and Translational Medicine.

[14]  Peter A. Jones,et al.  Reconfiguration of nucleosome-depleted regions at distal regulatory elements accompanies DNA methylation of enhancers and insulators in cancer , 2014, Genome research.

[15]  R. Kong,et al.  EZH2-mediated epigenetic suppression of long noncoding RNA SPRY4-IT1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial–mesenchymal transition , 2014, Cell Death and Disease.

[16]  S. Sarkar,et al.  Do epigenetic drug treatments hold the key to killing cancer progenitor cells? , 2014, Epigenomics.

[17]  T. Lange,et al.  Importance of altered glycoprotein-bound N- and O-glycans for epithelial-to-mesenchymal transition and adhesion of cancer cells. , 2014, Carbohydrate research.

[18]  A. Overholt,et al.  Fractionated stereotactic radiosurgery with concurrent temozolomide chemotherapy for locally recurrent glioblastoma multiforme: a prospective cohort study , 2014, OncoTargets and therapy.

[19]  I. Simpson.  An industry update: the latest developments in therapeutic delivery. , 2014, Therapeutic delivery.

[20]  M. Leary,et al.  Genetic and epigenetic aspects of breast cancer progression and therapy. , 2014, Anticancer research.

[21]  K. Lapinska,et al.  Histone Deacetylases (HDACs): Function, Mechanism, & Inhibition , 2014 .

[22]  Sarah A Heerboth,et al.  Use of Epigenetic Drugs in Disease: An Overview , 2014, Genetics & epigenetics.

[23]  Duane H. Hamilton,et al.  An immunotherapeutic intervention against tumor progression , 2014, Oncoimmunology.

[24]  M. Nieto.  Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells , 2013, Science.

[25]  Wai Leong Tam,et al.  The epigenetics of epithelial-mesenchymal plasticity in cancer , 2013, Nature Medicine.

[26]  S. Sarkar,et al.  Cancer Development, Progression, and Therapy: An Epigenetic Overview , 2013, International journal of molecular sciences.

[27]  Xinru Wang,et al.  NF-κB-mediated inflammation leading to EMT via miR-200c is involved in cell transformation induced by cigarette smoke extract. , 2013, Toxicological sciences : an official journal of the Society of Toxicology.

[28]  Corbin E. Meacham,et al.  Tumour heterogeneity and cancer cell plasticity , 2013, Nature.

[29]  Andrew E. Teschendorff,et al.  Age-associated epigenetic drift: implications, and a case of epigenetic thrift? , 2013, Human molecular genetics.

[30]  Ugo Ala,et al.  MicroRNA-Antagonism Regulates Breast Cancer Stemness and Metastasis via TET-Family-Dependent Chromatin Remodeling , 2013, Cell.

[31]  P. Pandolfi,et al.  The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. , 2013, Cell stem cell.

[32]  Wei Wang,et al.  Long non-coding RNA H19 increases bladder cancer metastasis by associating with EZH2 and inhibiting E-cadherin expression. , 2013, Cancer letters.

[33]  G. Ji,et al.  Sorafenib Inhibits Epithelial-Mesenchymal Transition through an Epigenetic-Based Mechanism in Human Lung Epithelial Cells , 2013, PloS one.

[34]  A. G. de Herreros,et al.  FGFR4 Role in Epithelial-Mesenchymal Transition and Its Therapeutic Value in Colorectal Cancer , 2013, PloS one.

[35]  J. Thiery,et al.  EMT impairs breast carcinoma cell susceptibility to CTL-mediated lysis through autophagy induction , 2013, Autophagy.

[36]  Davalyn R. Powell,et al.  Riding the crest of the wave: parallels between the neural crest and cancer in epithelial-to-mesenchymal transition and migration , 2013, Wiley interdisciplinary reviews. Systems biology and medicine.

[37]  Jia Liu,et al.  Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma , 2013, BMC Cancer.

[38]  S. Sarkar,et al.  Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy. , 2013, Epigenomics.

[39]  Sridhar Ramaswamy,et al.  Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition , 2013, Science.

[40]  G. Berx,et al.  Regulatory networks defining EMT during cancer initiation and progression , 2013, Nature Reviews Cancer.

[41]  Yuzhuo Wang,et al.  Integrin-linked kinase as a target for ERG-mediated invasive properties in prostate cancer models. , 2012, Carcinogenesis.

[42]  V. Valero,et al.  Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer , 2012, Molecular Cancer Therapeutics.

[43]  Yiran Huang,et al.  Upregulated MALAT-1 contributes to bladder cancer cell migration by inducing epithelial-to-mesenchymal transition. , 2012, Molecular bioSystems.

[44]  S. Sarkar,et al.  Anti-breast cancer effects of histone deacetylase inhibitors and calpain inhibitor. , 2012, Anticancer research.

[45]  Jae Hyuk Lee,et al.  CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion. , 2012, International journal of oncology.

[46]  Zhuchu Chen,et al.  Periostin, a stroma-associated protein, correlates with tumor invasiveness and progression in nasopharyngeal carcinoma , 2012, Clinical & Experimental Metastasis.

[47]  A. Rajasekaran,et al.  Dishonorable discharge: the oncogenic roles of cleaved E-cadherin fragments. , 2012, Cancer research.

[48]  I. Tinhofer,et al.  Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition , 2012, BMC Cancer.

[49]  V. Valero,et al.  Comparison of assay methods for detection of circulating tumor cells in metastatic breast cancer: AdnaGen AdnaTest BreastCancer Select/Detect™ versus Veridex CellSearch™ system , 2012, International journal of cancer.

[50]  J. Thiery,et al.  A Cell-Based Small Molecule Screening Method for Identifying Inhibitors of Epithelial-Mesenchymal Transition in Carcinoma , 2012, PloS one.

[51]  M. Duncan,et al.  aV integrins and TGF-β-induced EMT: a circle of regulation , 2012, Journal of cellular and molecular medicine.

[52]  Yong‐Nyun Kim,et al.  Anoikis Resistance: An Essential Prerequisite for Tumor Metastasis , 2012, International journal of cell biology.

[53]  F. Yu,et al.  MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells* , 2011, The Journal of Biological Chemistry.

[54]  J. Thiery,et al.  Mesenchymal Transition and Dissemination of Cancer Cells Is Driven by Myeloid-Derived Suppressor Cells Infiltrating the Primary Tumor , 2011, PLoS biology.

[55]  S. Sarkar,et al.  Histone deacetylase inhibitors reverse CpG methylation by regulating DNMT1 through ERK signaling. , 2011, Anticancer research.

[56]  Tin-Lap Lee,et al.  Methylation of an intronic region regulates miR-199a in testicular tumor malignancy , 2011, Oncogene.

[57]  Nicholas C. Flytzanis,et al.  An EMT–Driven Alternative Splicing Program Occurs in Human Breast Cancer and Modulates Cellular Phenotype , 2011, PLoS genetics.

[58]  C. Kleer,et al.  CCN6 (WISP3) decreases ZEB1-mediated EMT and invasion by attenuation of IGF-1 receptor signaling in breast cancer , 2011, Journal of Cell Science.

[59]  Ping Liu,et al.  Sorafenib inhibits transforming growth factor β1‐Mediated Epithelial‐Mesenchymal Transition and apoptosis in mouse hepatocytes , 2011, Hepatology.

[60]  R. Weinberg,et al.  A Perspective on Cancer Cell Metastasis , 2011, Science.

[61]  Chonghui Cheng,et al.  CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. , 2011, The Journal of clinical investigation.

[62]  Giuseppe Naso,et al.  Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients , 2011, Breast Cancer Research and Treatment.

[63]  S. Shankar,et al.  Resveratrol Inhibits Pancreatic Cancer Stem Cell Characteristics in Human and KrasG12D Transgenic Mice by Inhibiting Pluripotency Maintaining Factors and Epithelial-Mesenchymal Transition , 2011, PloS one.

[64]  Harald J. Maier,et al.  Epithelial-Mesenchymal Transition in Pancreatic Carcinoma , 2010, Cancers.

[65]  K. Hochedlinger,et al.  When fibroblasts MET iPSCs. , 2010, Cell stem cell.

[66]  J. Wrana,et al.  Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. , 2010, Cell stem cell.

[67]  H. Ford,et al.  Epithelial-Mesenchymal Transition in Cancer: Parallels Between Normal Development and Tumor Progression , 2010, Journal of Mammary Gland Biology and Neoplasia.

[68]  I. Leav,et al.  ERbeta impedes prostate cancer EMT by destabilizing HIF-1alpha and inhibiting VEGF-mediated snail nuclear localization: implications for Gleason grading. , 2010, Cancer cell.

[69]  H. Wallerand,et al.  Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines. , 2010, Urologic oncology.

[70]  Hideo Baba,et al.  Epithelial–mesenchymal transition in cancer development and its clinical significance , 2010, Cancer science.

[71]  M. Gönen,et al.  Cellular and genetic diversity in the progression of in situ human breast carcinomas to an invasive phenotype. , 2010, The Journal of clinical investigation.

[72]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[73]  F. Vesuna,et al.  Interleukin-6 induces an epithelial–mesenchymal transition phenotype in human breast cancer cells , 2009, Oncogene.

[74]  Tanja Fehm,et al.  Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients , 2009, Breast Cancer Research.

[75]  R. Weinberg,et al.  Integrin β1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs , 2009, Proceedings of the National Academy of Sciences.

[76]  Gerhard Christofori,et al.  EMT, the cytoskeleton, and cancer cell invasion , 2009, Cancer and Metastasis Reviews.

[77]  W. Schiemann,et al.  Cox-2 inactivates Smad signaling and enhances EMT stimulated by TGF-beta through a PGE2-dependent mechanisms. , 2008, Carcinogenesis.

[78]  M. Mullendore,et al.  An orally bioavailable small-molecule inhibitor of Hedgehog signaling inhibits tumor initiation and metastasis in pancreatic cancer , 2008, Molecular Cancer Therapeutics.

[79]  K. Mchugh,et al.  Snail Regulates Cell-Matrix Adhesion by Regulation of the Expression of Integrins and Basement Membrane Proteins* , 2008, Journal of Biological Chemistry.

[80]  Ming-Jer Tang,et al.  Epithelial-Mesenchymal Transition in Cervical Cancer: Correlation with Tumor Progression, Epidermal Growth Factor Receptor Overexpression, and Snail Up-Regulation , 2008, Clinical Cancer Research.

[81]  K. Helin,et al.  Polycomb Complex 2 Is Required for E-cadherin Repression by the Snail1 Transcription Factor , 2008, Molecular and Cellular Biology.

[82]  E. Lander,et al.  Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. , 2008, Cancer research.

[83]  Susan G Hilsenbeck,et al.  Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. , 2008, Journal of the National Cancer Institute.

[84]  T. Fujii,et al.  Epithelial-to-mesenchymal transition and integrin-linked kinase mediate sensitivity to epidermal growth factor receptor inhibition in human hepatoma cells. , 2008, Cancer research.

[85]  A. Osunkoya,et al.  Insulin-like growth factor-I-dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells. , 2008, Cancer research.

[86]  Kou-Juey Wu,et al.  Direct regulation of TWIST by HIF-1α promotes metastasis , 2008, Nature Cell Biology.

[87]  Meijing Wang,et al.  INTERLEUKIN 18 IN THE HEART , 2007, Shock.

[88]  M. Hollingsworth,et al.  Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins , 2007, Journal of cellular biochemistry.

[89]  A. Carvalho,et al.  High Promoter Methylation Levels of APC Predict Poor Prognosis in Sextant Biopsies from Prostate Cancer Patients , 2007, Clinical Cancer Research.

[90]  R. Weinberg,et al.  Tumour invasion and metastasis initiated by microRNA-10b in breast cancer , 2007, Nature.

[91]  D. Cho,et al.  The dual effects of interleukin-18 in tumor progression. , 2007, Cellular & molecular immunology.

[92]  Kornelia Polyak,et al.  Breast Tumor Heterogeneity: Cancer Stem Cells or Clonal Evolution? , 2007, Cell cycle.

[93]  C. Ko,et al.  Validation of the 6th edition AJCC pancreatic cancer staging system , 2007, Cancer.

[94]  H. El‐Serag,et al.  Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. , 2007, Gastroenterology.

[95]  P. Maxwell,et al.  Reactivation of Snail Genes in Renal Fibrosis and Carcinomas: A Process of Reversed Embryogenesis? , 2007, Cell cycle.

[96]  C. Iacobuzio-Donahue,et al.  Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. , 2007, Cancer research.

[97]  M. Monden,et al.  Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer , 2007, British Journal of Cancer.

[98]  Adrian V. Lee,et al.  Constitutively Active Type I Insulin-Like Growth Factor Receptor Causes Transformation and Xenograft Growth of Immortalized Mammary Epithelial Cells and Is Accompanied by an Epithelial-to-Mesenchymal Transition Mediated by NF-κB and Snail , 2007, Molecular and Cellular Biology.

[99]  Timothy J. Yeatman,et al.  Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue , 2006, Clinical Cancer Research.

[100]  Jos Jonkers,et al.  Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis. , 2006, Cancer cell.

[101]  A. J. Valente,et al.  Interleukin-18-induced Human Coronary Artery Smooth Muscle Cell Migration Is Dependent on NF-κB- and AP-1-mediated Matrix Metalloproteinase-9 Expression and Is Inhibited by Atorvastatin* , 2006, Journal of Biological Chemistry.

[102]  C. Glackin,et al.  N-cadherin gene expression in prostate carcinoma is modulated by integrin-dependent nuclear translocation of Twist1. , 2006, Cancer research.

[103]  N. Kyprianou,et al.  Anoikis and survival connections in the tumor microenvironment: is there a role in prostate cancer metastasis? , 2005, Cancer research.

[104]  G. Giannelli,et al.  Laminin-5 with transforming growth factor-beta1 induces epithelial to mesenchymal transition in hepatocellular carcinoma. , 2005, Gastroenterology.

[105]  D. Brenner,et al.  Erratum: Liver fibrosis (Journal of Clinical Investigation (2005) 115 (209-218) DOI:10.1172/JCI200524282) , 2005 .

[106]  M. Hoque,et al.  A Quantitative Promoter Methylation Profile of Prostate Cancer , 2004, Clinical Cancer Research.

[107]  J. Venables.  Aberrant and Alternative Splicing in Cancer , 2004, Cancer Research.

[108]  Alison Stopeck,et al.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer. , 2004, The New England journal of medicine.

[109]  Stanley B. Brown,et al.  The present and future role of photodynamic therapy in cancer treatment. , 2004, The Lancet. Oncology.

[110]  I. Fabregat,et al.  Snail blocks the cell cycle and confers resistance to cell death. , 2004, Genes & development.

[111]  Ryan M. Anderson,et al.  Acquired Expression of Periostin by Human Breast Cancers Promotes Tumor Angiogenesis through Up-Regulation of Vascular Endothelial Growth Factor Receptor 2 Expression , 2004, Molecular and Cellular Biology.

[112]  A. Sihoe,et al.  Lung cancer staging. , 2004, The Journal of surgical research.

[113]  Jean Paul Thiery,et al.  Epithelial-mesenchymal transitions in development and pathologies. , 2003, Current opinion in cell biology.

[114]  M. King,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 , 2003, Science.

[115]  Alfonso Bellacosa,et al.  The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines. , 2003, Cancer research.

[116]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[117]  M. Loda,et al.  Elevated Serum Periostin Levels in Patients with Bone Metastases from Breast but not Lung Cancer , 2003, Breast Cancer Research and Treatment.

[118]  Constance E. Brinckerhoff,et al.  Matrix metalloproteinases: a tail of a frog that became a prince , 2002, Nature Reviews Molecular Cell Biology.

[119]  D. Takai,et al.  Large scale mapping of methylcytosines in CTCF-binding sites in the human H19 promoter and aberrant hypomethylation in human bladder cancer. , 2001, Human molecular genetics.

[120]  D. Andrews,et al.  Cytoplasmic O‐glycosylation prevents cell surface transport of E‐cadherin during apoptosis , 2001, The EMBO journal.

[121]  W. Reik,et al.  Epigenetic Reprogramming in Mammalian Development , 2001, Science.

[122]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[123]  R. Dahiya,et al.  Frequent methylation of estrogen receptor in prostate cancer: correlation with tumor progression. , 2000, Cancer research.

[124]  M. Albrecht,et al.  Fibronectin in human prostatic cells in vivo and in vitro: expression, distribution, and pathological significance , 1999, Histochemistry and Cell Biology.

[125]  G. Chamberlain,et al.  Induction , 1999, BMJ.

[126]  D. Horsfall,et al.  Elevated levels of versican but not decorin predict disease progression in early-stage prostate cancer. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[127]  L. Liotta,et al.  General mechanisms of metastasis , 1997, Cancer.

[128]  D. Roberts,et al.  Regulation of tumor growth and metastasis by thrombospondin‐1 , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[129]  R. Pearl,et al.  Colorectal cancer and peritoneal carcinomatosis. , 1996, Seminars in surgical oncology.

[130]  H. Baloglu,et al.  Tissue fibronectin levels of human prostatic cancer, as a tumor marker. , 1995, Cancer biochemistry biophysics.

[131]  A. Rustgi,et al.  CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma. , 1995, Cancer research.

[132]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[133]  P. Humphrey,et al.  Tenascin expression in prostatic hyperplasia, intraepithelial neoplasia, and carcinoma. , 1993, Human pathology.

[134]  M. Quintanilla,et al.  Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. , 1993, The American journal of pathology.

[135]  D. Simpson,et al.  Incidence , 1982 .

[136]  B. Hirschel,et al.  GRANULATION TISSUE AS A CONTRACTILE ORGAN , 1972, The Journal of experimental medicine.

[137]  Herbert Waldmann,et al.  Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA 1 and BRCA 2 , 2015 .

[138]  S. Sarkar,et al.  Methylation by DNMT1 is more Efficient in Chronic Lymphocytic Leukemia Cells than in Normal Cells , 2015 .

[139]  X. Cui,et al.  LncRNA expression signatures of twist-induced epithelial-to-mesenchymal transition in MCF10A cells. , 2014, Cellular signalling.

[140]  F. Hamdy,et al.  Platinum Priority – Collaborative Review – Prostate Cancer MicroRNA in Prostate , Bladder , and Kidney Cancer : A Systematic Review , 2011 .

[141]  Dianliang Zhang,et al.  Activation of NF-B upregulates Snail and consequent repression of E-cadherin in cholangiocarcinoma cell invasion. , 2011, Hepato-gastroenterology.

[142]  Tara L. Kieffer,et al.  Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis , 2009 .

[143]  T. Fujita,et al.  Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells. , 2007, Journal of the American Society of Nephrology : JASN.

[144]  V. Kosma,et al.  Versican in nonsmall cell lung cancer: relation to hyaluronan, clinicopathologic factors, and prognosis. , 2005, Human pathology.

[145]  Youhua Liu.  Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention. , 2004, Journal of the American Society of Nephrology : JASN.

[146]  M. Pinzani.  Liver fibrosis , 2004, Springer Seminars in Immunopathology.

[147]  Anne Vincent-Salomon,et al.  Epithelial–mesenchymal transition in breast cancer development , 2003 .

[148]  M. Mareel,et al.  Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. , 2001, Journal of cell science.